Strategy of adherence to long-term bronchial asthma control formation
https://doi.org/10.30629/0023-2149-2020-98-11-12-772-780
Abstract
One of the approaches to the formation of adherence to long-term treatment of patients with bronchial asthma, the basis of which is the introduction of a learning factor into their therapeutic complex, is considered. The cognitive strategy of individual and group education of patients in the Asthma School environment helps to awaken the patient’s activity at the level of competence in the management of the illness, and cooperation with the attending physician. The patient consistently acquires the necessary knowledge, useful skills and confidence in the importance of personal participation in the treatment of this disease, moving from compliance to informed adherence to treatment. The significant advantages of long-term treatment of bronchial asthma, in which trained patients are involved, are shown.
About the Authors
S. A. SobchenkoRussian Federation
191015, Saint Petersburg
S. N. Evtyushkina
Russian Federation
191015, Saint Petersburg
M. A. Kharitonov
Russian Federation
194044, Saint Petersburg
V. A. Kazantsev
Russian Federation
194044, Saint Petersburg
D. Yu. Butko
Russian Federation
194100, Saint Petersburg
D. V. Cherkashin
Russian Federation
194044, Saint Petersburg
S. L. Grishaev
Russian Federation
Sergei L. Grishaev — MD, professor, deputy head of Department of Naval Therapy
194044, Saint Petersburg
References
1. Engelkes M. et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur. Respir. J. 2015;45(2):396– 407. DOI: 10.1183/09031936.00075614
2. Williams L.K., Pladevall M., Xi H., Peterson E.L. et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 2004;114(6):1288–1293. DOI: 10.1016/j.jaci.2004.09.028
3. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland. 2003. [Electronic resource]. URL: www.who.int/chp/knowledge/publications/adherence_full_report.pdf.
4. Hjelle L., D.Ziegler D. Personality Theories. SPb.: Piter, 3th ed.: McGrow-Hill, 1997;6:271–303. (in Russian)]
5. ГGlobal strategy for asthma management and prevention. Revised 2011. Pod red.A.S. Belevskogo. Moscow: Rossiyskoye respiratornoye obshchestvo, 2012:108. (in Russian)
6. Global strategy for asthma management and prevention. Revised 2015 y. Еd. A.S. Belevskogo. Moscow: Rossiyskoye respiratornoye obshchestvo, 2015:150. (in Russian)
7. Nenasheva N.M. Bronchial asthma. Modern view of the problem. Moscow: GEOTAR-Media, 2018:82–83. (in Russian)]
8. Trofimov V.I., Fedoseyev G.B. Treatment and prevention of bronchial asthma. In book: The many faces of asthma, diagnosis, treatment and prevention. Pod red. G.B. Fedoseyeva, V.I. Trofimova, M.A. Petrovoy. Saint-Petersburg: Nordmedizdat, 2011;12:320–332. (in Russian)
9. Federal’nyye klinicheskiye rekomendatsii po diagnostike i lecheniyu bronkhial’noy astmy. Moscow: Rossiyskoye respiratornoye obshchestvo, 2016:55. (in Russian)
10. Bateman E.D., Boushey H.A, Bousguet J. et all. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Amer. J. Respir. Crit. Care. Med. 2004;170:836–844. DOI: 10.1164/rccm.200401-033OC
11. Price D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim. Care Respir. Med. 2014;24:14009. DOI: 10.1038/npjpcrm.2014.9
12. Arkhipov V.V., Grigorieva E.V., Gavrishina E.V. Control of bronchial asthma in Russia: results of a multicenter observational study by NIКА. Pul’monologiya. 2011;(6):87–93. (in Russian) DOI: 10.18093/0869-0189-2011-0-6-87-93
13. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. Royal College of Physicians. London; 2014.
14. Haughney J., Price D., Kaplan A. et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir. Med. 2008;102(12):1681–1693. DOI: 10.1016/j.rmed.2008.08.003
15. Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037
16. Melani A.S., Bonavia M., Cilenti V. et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir. Med. 2011;105:930–938. DOI: 10.1016/j.rmed.2011.01.005
17. Virchow J.C., Crompton G.K., Dal Negro R. Importance of inhaler devices in the management of airway disease. Respir. Med. 2008;102(1):10–19. DOI: 10.1016/j.rmed.2007.07.031
18. Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037
19. Di Matteo M.R. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med. Care. 2004;42(3):200–209. DOI: 10.1097/01.mlr.0000114908.90348.f9
20. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65–72. [Electronic resource]. URL: https://www.eu-patient.eu/globalassets/policy/adherence-compliance-concordance/adherence-paper-final-rev_external.pdf.
21. van Boven J.F., Trappenburg J.C., van der Molen T., Chavannes N.H. Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim. Care Resp. Med. 2015;25:15046. DOI: 10.1038/npjpcrm.2015.46
22. Nenasheva N.M. how to increase adherence to treatment and improve control for bronchial asthma, or the impossible is possible. Effektivnaya farmakoterapiya. 2019;15(15):18–23. (in Russian). DOI:10.33978/2307-3586-2019-15-15-18-23
23. Schwartz Yu.G., Naumova E.A. Patients‘ Commitment to treatment from the standpoint of evidence-based medicine. Mezhdunarodnyy meditsinskiy zhurnal. 2005;3:120–125. (in Russian)
24. Jin J., Sklar G.E., Min Sen Oh V., Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther. Clin. Risk Manag. 2008;4(1):269–286. DOI: 10.2147/tcrm.s1458
25. Pedersen, S. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control Study. S. Pedersen [et al.]. J. Allergy Clin. Immunol. 2007;120(5):1036–1042. DOI: 10.1016/j.jaci.2007.07.016
26. Sobchenko S.A. Features of the course and organization of long-term treatment of late asthma. Dissertatsiya… dok. med. nauk. SPb, 1997:302. (in Russian)
27. Ignasio-Garcio J.M. Gonsales-Santos P. Asthma self-management education program by me monitoring of peak expiratory flow. Amer. J. Respir. Crit. Care Med. 1995;151:353–359. DOI: 10.1164/ajrccm.151.2.7842191
28. Partridge M.R. Patient education and delivery of care. Asthma. European respiratory monograph. 2003;8:449–453.
29. Reddel H.K. Peak flow monitoring in clinical practice and clinical asthma trials. Curr. Opin. Pulm. Med. 2006;12(1):75–81. DOI: 10.1097/01.mcp.0000198065.65704.08
30. Tsoy A.N., Arkhipov V.V. Bronchial asthma: new solutions. Moscow: OOO «Meditsinskoye informatsionnoye agentstvo», 2007:38–46. (in Russian)
31. International consensus report on diagnosis and management of asthma. Bethesda, Maryland, USA: National Heart, Lung and Blood Institutes of Health. Bethesda, 1992. Eur. Respir. J. Publication no. 92-3091. 1992;(5):601–641.
32. Pospelova S.N. Clinical and laboratory data and indicators of quality of life in the control of the course of bronchial asthma (according to long-term treatment of patients «Аsthma-school»). Dissertatsiya ... kand. med. nauk. SPb., 2012:203. (in Russian)
33. Chrystyn H., Price D. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim. Care Respir. J. 2009;18(4):243–249. DOI: 10.4104/pcrj.2009.00029
34. Haynes R.B., McDonald H., Garg A.X., Montague P.R. Interventions for helping patients to follow prescriptions for medication (Cochrane review). Cochrane Database Syst. Rev. 2002;(2):CD000011. DOI: 10.1002/14651858.CD000011
35. McKinstry B. Do patients wish to be involved in decisionmaking in the consultation? A cross sectional survey with video vignettes. BMJ. 2000;321:867–871 DOI: 10.1136/bmj.321.7265.867
36. Worsley S, Snowise N., Halpin D.M.G. Clinical effectiveness of oncedaily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research. 2019;(5):00061-2019; DOI: 10.1183/23120541.00061-2019
Review
For citations:
Sobchenko S.A., Evtyushkina S.N., Kharitonov M.A., Kazantsev V.A., Butko D.Yu., Cherkashin D.V., Grishaev S.L. Strategy of adherence to long-term bronchial asthma control formation. Clinical Medicine (Russian Journal). 2020;98(11-12):772-780. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-11-12-772-780